Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)-targeting antibody-drug conjugate (ADC), in combination with bevacizumab in patients with platinum-resistant ovarian cancer. - Gilbert, Lucy; Oaknin, Ana; Matulonis, Ursula A.; Mantia-Smaldone, Gina M.; Lim, Peter C.; Castro, Cesar M.; Provencher, Diane; Memarzadeh, Sanaz; Method, Michael; Wang, Jiuzhou; Moore, Kathleen N.; O'Malley, David M. (Gynecologic Oncology, 2023)